Compare FuelCell Energy Inc (FCEL) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FuelCell Energy Inc vs Cassava Sciences Inc — how do they compare? FuelCell Energy Inc trades at $17.6 (market cap $1.47B), while Cassava Sciences Inc trades at $0.82 (market cap $39.40M). The key difference: FuelCell Energy Inc is far larger — about 37.3× Cassava Sciences Inc's market cap, and FuelCell Energy Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold FuelCell Energy Inc for 48 Days and Cassava Sciences Inc for 37 Days on average.
| FCEL | FLNA | |
|---|---|---|
Market Cap | $1.47B | $39.40M |
Volume | 12,559,948 | 759,018 |
Sector | Industrials | Health |
52-Week High | $36.01 | $4.64 |
52-Week Low | $6.00 | $0.68 |
Typical Hold Time | 48 Days | 37 Days |
Enterprise Value | $1.05B | -$43.28M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FCEL stock trades at $18.37, down 11.07% over 24 hours, with a bullish technical signal from moving averages but neutral oscillators. The company reported revenue of $158.16M in 2025 but sustained a net loss of $187.90M, reflecting negative profit margins. Recent news highlights a securities class action lawsuit filed against the company, alleging disclosure failures between June and September 2026.
The outlook remains challenged by persistent losses and high cash burn, though analyst consensus suggests a $21.57 price target with 40% buy ratings. Key risks include the class action litigation, execution on profitability, and reliance on financing activities to fund operations.
FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.
The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
